CS logo
small CS logo
Ark Clinical Research

Long Beach, California, United States
Medical clinic in Long Beach, California
2600 Redondo Ave Ste. 400, Long Beach, CA 90806

About Ark Clinical Research


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials

Clinical Trials at Ark Clinical Research


During the past decade, Ark Clinical Research conducted 26 clinical trials. In the 10-year time frame, 26 clinical trials started and 8 clinical trials were completed, i.e. on average, 30.8% percent of trials that started reached the finish line to date. In the past 5 years, 22 clinical trials started and 7 clinical trials were completed. i.e. 31.8% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Open-Label Extension Study Evaluating Long Term Safety in Patients With Type 1 Gaucher Disease Receiving DRX008A (ERT)
2004-09-13
2008-01-31
Completed
10
Study Evaluating Safety And Efficacy Of Moroctocog Alfa (AF-CC) In Previously Treated Hemophilia A Patients
2009-12-01
2016-04-01
Completed
37
A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years
2011-09-27
2016-08-10
Completed
295
A 12-Month Study To Evaluate The Safety And Tolerability Of Pregabalin As Add-On Therapy In Pediatric Subjects 1 Month To 16 Years Of Age With Partial Onset Seizures And Pediatric And Adult Subjects 5 To 65 Years Of Age With Primary Generalized Tonic-Clonic Seizures
2012-02-21
2019-08-22
Completed
605
Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes
2014-01-01
2014-12-01
Completed
5,237
Pediatric Vasculitis Initiative
2013-01-01
2025-03-01
Recruiting
1,600
A Safety, Efficacy, and Tolerability Trial of Pregabalin as Add-On Treatment in Pediatric Subjects <4 Years of Age With Partial Onset Seizures.
2014-09-16
2018-03-13
Completed
175
Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE)
2017-03-27
2022-05-24
Completed
290

Rows per page:

1–16 of 16

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Ark Clinical Research" #1 sponsor was "Janssen Vaccines & Prevention B.V." with 6 trials, followed by "Pfizer" with 6 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored, "Vaxart" with 2 trials sponsored and "Bavarian Nordic" with 2 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Ark Clinical Research" #1 collaborator was "AbCellera Biologics Inc." with 1 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator, "Ironwood Pharmaceuticals, Inc." with 1 trials as a collaborator, "JSS Medical Research Inc." with 1 trials as a collaborator and "Shanghai Junshi Bioscience Co., Ltd." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.
Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Ark Clinical Research


According to Clinical.Site data, the most researched conditions in "Ark Clinical Research" are "COVID-19" (7 trials), "Influenza, Human" (2 trials), "Acute Respiratory Infection" (1 trials), "Allergic Contact Dermatitis" (1 trials) and "Atopic Dermatitis" (1 trials). Many other conditions were trialed in "Ark Clinical Research" in a lesser frequency.

Clinical Trials Intervention Types at Ark Clinical Research


Most popular intervention types in "Ark Clinical Research" are "Drug" (15 trials), "Biological" (11 trials), "Other" (6 trials), "Combination Product" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (17 trials), "Ad26.COV2.S" (4 trials), "PF-07321332" (2 trials), "Ritonavir" (2 trials) and "Abrocitinib 200 mg" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Ark Clinical Research


The vast majority of trials in "Ark Clinical Research" are 26 trials for "All" genders.

Clinical Trials Status at Ark Clinical Research


Currently, there are NaN active trials in "Ark Clinical Research". undefined are not yet recruiting, 4 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Ark Clinical Research, undefined suspended trials, and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Ark Clinical Research, 3 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status